Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy in patients with advanced ovarian cancer (OVHIPEC-1): final survival analysis of a randomised, controlled, phase 3 trial
S. Lot Aronson, Marta López‐Yurda, Simone N. Koole, Jules H. Schagen van Leeuwen, Hendrik W.R. Schreuder, Ralph H.M. Hermans, Ignace H. J. T. de Hingh, Mignon D J M van Gent, Henriëtte J.G. Arts, Maaike A. van der Aa, Peter A. van Dam, Peter Vuylsteke, Arend G. J. Aalbers, Victor J. Verwaal, Koen Van de Vijver, Neil K. Aaronson, Gabe S. Sonke, Willemien J. van Driel
Topics & Concepts
MedicineHyperthermic intraperitoneal chemotherapyClinical endpointSurgeryOvarian cancerCytoreductive surgeryCarboplatinRandomized controlled trialPopulationChemotherapyInternal medicineCancerOncologyCisplatinEnvironmental healthIntraperitoneal and Appendiceal MalignanciesOvarian cancer diagnosis and treatmentBladder and Urothelial Cancer Treatments